Role of D(T)PACE-based regimens as treatment of multiple myeloma with extramedullary relapse or refractory disease-Reference-Cited by-同舟云学术

Role of D(T)PACE-based regimens as treatment of multiple myeloma with extramedullary relapse or refractory disease

Published:2021-04-01 Issue:9 Volume:62 Page:2235-2241
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Huynh Tony¹,Corre Elise¹,Lemonnier Marie-Paule¹,Duléry Rémy¹,Marjanovic Zora¹,Jaff Nabaz¹,Lapusan Simona¹,Mohty Mohamad¹²³,Garderet Laurent¹²,Coppo Paul¹²⁴⁵

Affiliation:

1. Service d’Hématologie et thérapie cellulaire, Hôpital Saint-Antoine, AP-HP, Paris, France

2. Sorbonne Université, Paris, France

3. INSERM UMRs 938, Paris, France

4. Centre de Référence des Microangiopathies Thrombotiques (CNR-MAT), AP-HP, Paris, France

5. Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1907373

Reference21 articles.

1. From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

2. Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

3. Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

4. Chimeric antigen receptor T-cell therapies for multiple myeloma

5. Extramedullary multiple myeloma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Megalosplenia as an initial manifestation of multiple myeloma with a novel CYLD gene mutation: A case report and literature review;Medicine;2024-04-05

2. Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies;Annals of Hematology;2023-09-05

3. Experts’ consensus on the definition and management of high risk multiple myeloma;Frontiers in Oncology;2023-01-23

4. Antineoplastics;Reactions Weekly;2023-01-07

5. VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience;Annals of Hematology;2022-11-16